Short answer
Bausch Health Companies Inc (BHC) filed an 8-K current report with the SEC on October 28, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Bausch Health announced third-quarter results for the quarter ended September 30, 2026.
Bausch Health Companies Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Bausch Health announced third-quarter results for the quarter ended September 30, 2026
- Press release includes financial information as of and for the quarter ended September 30, 2026
- Exhibit 99.1 contains the detailed results investors should review for performance metrics and guidance
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $2.94B, up 10%; Adjusted EBITDA $1.305B, up 32%, signaling strong operating leverage
- GAAP EPS $1.15 versus $0.48; adjusted EPS $1.77 versus $1.16, a 53% increase
- Cash from operations $813M, up 101%; cash balance $2.485B supports more than $500M quarterly net debt reduction
- Salix growth led performance, with revenue up 16% and Xifaxan revenue up 16%; Solta organic revenue declined 4%
- Full-year guidance raised: revenue $10.975B-$11.175B, Adjusted EBITDA $4.315B-$4.415B, adjusted operating cash flow $1.600B-$1.675B; $50M buyback offsets anticipated 2027 equity dilution
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Bausch Health Companies Inc 8-K filings
Get the next BHC 8-K as it lands
Follow BHC for push alerts, or ask the research agent what this filing means.